Watchdog sues FDA for dragging its feet on Parkinson's drug warnings

[Farooqji]

Moving the FDA's gears can be a lengthy process, particularly when it comes to citizen petitions. But after waiting two and a half years for regulators to stiffen impulse-control warnings on dopamine-driving Parkinson's drugs, one watchdog group ran out of patience.

Public Citizen sued the agency Monday, demanding a D.C. district court force the FDA to add black box warnings to six dopamine agonists. The group cited reports of pathological gambling, compulsive eating and shopping and hypersexual behavior among patients using the drugs.

The lawsuit follows up on a 2016 citizen's petition demanding warnings on GlaxoSmithKline’s Requip, Boehringer Ingelheim’s Mirapex and UCB’s Neupro and three other meds

fiercepharma.com/pharma/pub...

[park_bear]

Such warnings long overdue.

[Rebtar]

Dr. Daniel Jeanmonod sonimodul.ch

This clinic has been having superior results, to the US clinics.

[parkie13 in reply to Rebtar]

Do you know anybody personally and how did they do?

[Rebtar in reply to parkie13]

Yes, not personally but a member of a facebook group, her results were excellent.

[MBAnderson]

Hallelujah!!

[FMundo]

Says a lot about the FDA's looking out for the interests of . . . the Pharmaceutical Industry.

Has the Trumpster appointed a lobbyist to head up that department yet ?

[Erniediaz1018]

Excellent!!

[tarz]

Here's a warning that should always be applied - youtube.com/watch?v=6K4tCA0...(Not working as expected?)